SUMO1 hinders α‐Synuclein fibrillation by inducing structural compaction
Authors:
- 17 April 2023
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 32 (5) , e4632
Abstract
Small Ubiquitin‐like Modifier 1 (SUMO1) is an essential protein for many cellular functions, including regulation, signaling, etc., achieved by a process known as SUMOylation, which involves covalent attachment of SUMO1 to target proteins. SUMO1 also regulates the function of several proteins via non‐covalent interactions involving the hydrophobic patch in the target protein identified as SUMO Binding or Interacting Motif (SBM/SIM). Here, we demonstrate a crucial functional potential of SUMO1 mediated by its non‐covalent interactions with α‐Synuclein, a protein responsible for many neurodegenerative diseases called α‐Synucleinopathies. SUMO1 hinders the fibrillation of α‐Synuclein, an intrinsically disordered protein (IDP) that undergoes a transition to β‐structures during the fibrillation process. Using a plethora of biophysical techniques, we show that SUMO1 transiently binds to the N‐terminus region of α‐Synuclein non‐covalently and causes structural compaction, which hinders the self‐association process and thereby delays the fibrillation process. On the one hand, this study demonstrates an essential functional role of SUMO1 protein concerning neurodegeneration; it also illustrates the commonly stated mechanism that IDPs carry out multiple functions by structural adaptation to suit specific target proteins, on the other. Residue‐level details about the SUMO1‐α‐Synuclein interaction obtained here also serve as a reliable approach for investigating the detailed mechanisms of IDP functions.Keywords
Funding Information
- Anusandhan National Research Foundation (EMR/2016/002798)
This publication has 84 references indexed in Scilit:
- Structural Intermediates during α-Synuclein Fibrillogenesis on Phospholipid VesiclesJournal of the American Chemical Society, 2012
- Proteasome inhibition induces α-synuclein SUMOylation and aggregate formationJournal of the Neurological Sciences, 2011
- Structured Regions of α-Synuclein Fibrils Include the Early-Onset Parkinson's Disease Mutation SitesJournal of Molecular Biology, 2011
- SUMO junction—what's your function?EMBO Reports, 2007
- Relationships between the Sequence of α-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast ToxicityJournal of Molecular Biology, 2007
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. WrightJournal of Molecular Biology, 2001
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996